Tychon Biosciences
Minneapolis, US · Founded 2014 · Delaware LLC
Founders & leadership
DJ
Danny J. CunaginExecutive
MS
Mark SylvesterExecutive
TD
Troy D. KopischkeExecutive
Reported raises · per SEC filings
Form D private placements$670.7K disclosed across 2 rounds · 2015–2018
▶$200KraisedOct 2018 · 2 investors · Other TechnologyRule 506(b)
▶$200KraisedOct 2018 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Charles Muscoplat, PhDExecutive Officer
- Danny J. CunaginExecutive Officer, Director
- Mark SylvesterExecutive Officer
- Arek Z. Dudek, MD PhDExecutive Officer
- John MacDonald, PhDExecutive Officer
- Troy D. KopischkeExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $200K
- Minimum investment
- $50K
- First sale
- Oct 2018
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
▶$470.7KraisedNov 2015 · 7 investors · Other TechnologyRule 506(b)
▶$470.7KraisedNov 2015 · 7 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Danny J. CunaginExecutive Officer, Director
- Mark SylvesterExecutive Officer
- Troy D. KopischkeExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $470.7K
- First sale
- Nov 2015
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Tychon Biosciences raised?
- Tychon Biosciences has disclosed $670.7K raised across 2 rounds.
- Where is Tychon Biosciences headquartered?
- Tychon Biosciences is headquartered in Minneapolis, US.